
CDC Survey: About 1 in 10 U.S. Adults Used a GLP-1 in 2025, and 44% of Users Changed How They Took It
Notes de l’épisode
A new CDC report published November 12, 2026, in the Morbidity and Mortality Weekly Report looks at how U.S. adults used GLP-1 medications in 2025. In a national survey of 8,118 adults through CDC's Rapid Surveys System, collected in July and August 2025, about one in 10 adults (9.8%) reported taking a GLP-1 medication in the past year, including 47.4% of adults who reported ever having diabetes. Among the 976 users, 22.6% reported taking a compounded version and another 8.8% did not know whether theirs was compounded. Forty-four percent said they had modified their use from the way it was prescribed, most often by skipping doses (28%). Modification was more common among adults 18 to 39 than among those 65 and older (54% vs 30%) and among compounded-drug users than other users (62% vs 36%). Among those who modified their use, 38% cited cost and 36% availability; about 12% of all users reduced or stopped because of side effects or symptoms. The CDC notes that compounded GLP-1 medications are not reviewed by the FDA for safety, effectiveness or quality before they are marketed, and that the findings are self-reported, from online panels with low response rates.
Sources
- CDC Morbidity and Mortality Weekly Report (Nov 12, 2026), Use of Glucagon-Like Peptide-1 Medications and Modified Medication Use Among Adults — United States, 2025: cdc.gov
- CDC National Center for Health Statistics, Rapid Surveys System Round 7 datasets and documentation: cdc.gov
- U.S. Food and Drug Administration, FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize: fda.gov
- Ars Technica (Nov 13, 2026), Millions of Americans are not taking their GLP-1 drugs as prescribed: arstechnica.com
- Quartz (Nov 13, 2026), Nearly half of U.S. weight-loss drug users are changing how they take them, CDC finds: qz.com
Cover: original code-generated illustration (no photo).
This episode is for information only and is not medical advice. Always talk to your doctor before starting, stopping, or changing any medication.
Visit glp1newspaper.com for today's stories and free email alerts.
Tous les épisodes de GLP-1 Newspaper: Daily Ozempic, Zepbound & Weight-Loss Drug News